About Us
ABOUT US
Shanghai Yingrui Biopharma Co.,Ltd.
Shanghai Yingrui Biopharma Co., Ltd. was established in 2009 and is a high-tech biopharmaceutical enterprise specializing in the research and development, production, and sales of active pharmaceutical ingredients(APIs) and their intermediates. The company is located in Block 104, Minhang District, Shanghai, with an R&D center, pilot workshops, production bases, and stable cooperative factories.
The company has an experienced technical research and development team and a high-quality management team, and has established long-term and stable cooperative relationships with multiple universities in Shanghai. Our team continuously consolidates professional knowledge and has accumulated rich experience in route design and optimization. We can provide timely and efficient customized synthesis services, process route optimization services, and diversified services such as scaling up production.
The company is equipped with multiple liquid phase, gas phase, infrared, titration and other analytical and testing instruments, which can not only meet the needs of customers from research and development to production, but also ensure that we can provide stable high-quality products to the market. The company has established long-term and stable partnerships with many well-known pharmaceutical companies both domestically and internationally.
Corporate Culture
Corporate spirit
People oriented, technological innovation, excellent quality, integrity and win-win!
Company management philosophy
Quality and efficiency to create the market, integrity management to build the brand, being attentive and considerate to the service, and technological innovation to seek development! Striving for customers’ satisfaction, corporate profits and social benefit!
Company Development Strategy
Take the market demand as the guidance, take the product innovation as the strategy, take the customer satisfaction as the goal, take the company profit as the goal.
Service Philosophy
Customer first, solving problems beyond expectations.
